drugset / Trial / NCT05298098
Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure
RandomizedParallel-groupSingle-blindTreatment
Summary
Acute decompensated heart failure (HF) is one of the most common cardiologic issues in emergency departments. Loop diuretics have long been recognized as the key for the treatment of Acute Decompensated Heart Failure (ADHF).However, chronic treatment with diuretics may limit their response and deteriorates the renal function. The hypertonic saline solution (HSS) has been proposed in recent years as an adjunctive therapy for intravenous loop diuretics to improve or restore their initial pharmacological efficacy. In this study the investigators will evaluate the effectiveness of HSS as an adjunct to i.v. furosemide in patients admitted for AHF with renal dysfunction
Timeline
- Start
- 2018-07-01
- Primary completion
- 2023-09
- Completion
- 2023-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hypertonic Saline Solution | Unknown | 10 % | Intravenous |
| Comparator | Hypertonic Saline Solution | Unknown | 50 ml | Intravenous |
| Comparator | Furosemide | Other / unclassified | 250 mg | Intravenous |